AAMI規格 TIR106, 2024: Microbiological methods-Understanding and use of product bioburden data (PDF/シングルユーザー)

AAMI規格 TIR106, 2024(PDF/シングルユーザー)

産業規格・仕様書  >  AAMI  > 




AAMI規格 TIR106, 2024(PDF/シングルユーザー)

47,850(税込)

数量

書名

AAMI TIR106, 2024: Microbiological methods-Understanding and use of product bioburden data
AAMI規格 TIR106, 2024: 微生物学的手法 製品バイオバーデンデータの理解と活用
発行元 Association for the Advancement of Medical Instrumentation (AAMI)
発行年/月 2024年3月
装丁 PDF/シングルユーザー
ページ数 - ページ
発送予定 1-2営業日以内
※PDF版のみのお取り扱いです
※当ウェブ・ショップに未掲載のAAMI規格につきましては、別途お問合せ下さいませ。
※掲載の規格は、当ウェブ・ショップに掲載時点で確認できた最新版でございます。
最新の発行状況につきましては受注時に改めて確認をさせて頂きますので予めご了承下さい。

 

Description

General
This technical information report (TIR) is a compilation of available information regarding test protocols, materials, test soils, and acceptance criteria that can be used by medical device manufacturers to validate cleaning processes for reusable medical devices.

Inclusions
This TIR covers the validation of cleaning processes for medical devices that are intended and labeled by the manufacturer for reprocessing and reuse. Such devices include those that are intended for routine reprocessing and reuse (e.g., surgical instruments) and certain implant accessories (e.g., orthopedic screws) that are provided as parts of sets and that are intended and labeled by the manufacturer for reprocessing if not used during a particular procedure.

The scope of this TIR Includes the following topics:
a) Device design and material considerations
b) Available cleaning processes
c) Test soils
d) Test methods
e) Test equipment
f) Acceptance criteria
g) Regulatory considerations

This TIR also provides numerous literature references and a sample cleaning validation outline.

Exclusions
This TIR does not cover the performance of procedures for cleaning reusable medical devices in health care facilities (see ANSI/AAMI ST79), nor does it cover procedures for reprocessing single-use medical devices and hemodialyzers in health care facilities (see FDA, 2000b; and ANSI/AAMI RD47).

The test protocols, test soils, and acceptance criteria described in this TIR do not necessarily apply to the validation of cleaning processes for medical devices contaminated with prions, such as the prion that causes Creutzfeldt-Jakob disease (CJD); such devices could require specialized processing steps. For information regarding the decontamination of devices exposed to prions, see ANSI/AAMI ST79, AORN (2011a), Favero and Bond (2001), and Rutala and Weber (2010), as well as the recommendations of the Centers for Disease Control and Prevention.